{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:27:13Z","timestamp":1776378433132,"version":"3.51.2"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:00:00Z","timestamp":1759881600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Vessels, Thrombosis & Hemostasis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.bvth.2025.100114","type":"journal-article","created":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T05:57:20Z","timestamp":1760075840000},"page":"100114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of hemoglobin F in sickle cell disease complications: a descriptive secondary analysis"],"prefix":"10.1016","volume":"3","author":[{"given":"Heath","family":"Aston","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elexis","family":"Price","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Wernecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Hazenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3487-3073","authenticated-orcid":false,"given":"Daniel","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siera","family":"Gollan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-7768-0465","authenticated-orcid":false,"given":"Girindra","family":"Raval","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-8087","authenticated-orcid":false,"given":"Abdullah","family":"Kutlar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bvth.2025.100114_bib1","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1182\/asheducation-2010.1.418","article-title":"Sickle-cell trait: novel clinical significance","volume":"2010","author":"Key","year":"2010","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.bvth.2025.100114_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/bloodadvances.2024013693","article-title":"Is allogeneic transplantation for sickle cell disease still relevant in the era of gene therapy?","volume":"9","author":"Jones","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.bvth.2025.100114_bib3","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"10.1016\/j.bvth.2025.100114_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1001\/jama.2022.10233","article-title":"Sickle cell disease: a review","volume":"328","author":"Kavanagh","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.bvth.2025.100114_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1146\/annurev-pathmechdis-012418-012838","article-title":"Pathophysiology of sickle cell disease","volume":"14","author":"Sundd","year":"2019","journal-title":"Annu Rev Pathol"},{"issue":"38","key":"10.1016\/j.bvth.2025.100114_bib6","doi-asserted-by":"crossref","first-page":"e35237","DOI":"10.1097\/MD.0000000000035237","article-title":"Understanding sickle cell disease: causes, symptoms, and treatment options","volume":"102","author":"Elendu","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.bvth.2025.100114_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/ejh.13212","article-title":"Insight into the complex pathophysiology of sickle cell anaemia and possible treatment","volume":"102","author":"Piccin","year":"2019","journal-title":"Eur J Haematol"},{"issue":"21","key":"10.1016\/j.bvth.2025.100114_bib8","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1182\/blood.2020007645","article-title":"Fetal hemoglobin in sickle cell anemia","volume":"136","author":"Steinberg","year":"2020","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.bvth.2025.100114_bib9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.bvth.2025.100114_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2217\/pmt-2023-0031","article-title":"Crizanlizumab in sickle cell disease","volume":"13","author":"Kaur","year":"2023","journal-title":"Pain Manag"},{"key":"10.1016\/j.bvth.2025.100114_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/20406207211001136","article-title":"Voxelotor: alteration of sickle cell disease pathophysiology by a first-in-class polymerization inhibitor","volume":"12","author":"Glaros","year":"2021","journal-title":"Ther Adv Hematol"},{"issue":"13","key":"10.1016\/j.bvth.2025.100114_bib12","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1182\/bloodadvances.2022009147","article-title":"Natural history and rate of progression of retinopathy in adult patients with sickle cell disease: an 11-year follow-up study","volume":"7","author":"Brandsen","year":"2023","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.bvth.2025.100114_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2215\/CJN.03940415","article-title":"Kidney disease among patients with sickle cell disease, hemoglobin SS and SC","volume":"11","author":"Drawz","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.bvth.2025.100114_bib14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1056\/NEJMoa035477","article-title":"Pulmonary hypertension as a risk factor for death in patients with sickle cell disease","volume":"350","author":"Gladwin","year":"2004","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.bvth.2025.100114_bib15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1542\/peds.2010-1791","article-title":"Quality-of-care indicators for children with sickle cell disease","volume":"128","author":"Wang","year":"2011","journal-title":"Pediatrics"},{"issue":"10","key":"10.1016\/j.bvth.2025.100114_bib16","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.bvth.2025.100114_bib17","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.3324\/haematol.2019.239350","article-title":"The molecular basis for the prothrombotic state in sickle cell disease","volume":"105","author":"Shet","year":"2020","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.bvth.2025.100114_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s11239-013-0895-y","article-title":"Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know","volume":"35","author":"Naik","year":"2013","journal-title":"J Thromb Thrombolysis"},{"issue":"8","key":"10.1016\/j.bvth.2025.100114_bib19","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1182\/bloodadvances.2019001142","article-title":"American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults","volume":"4","author":"DeBaun","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.bvth.2025.100114_bib20","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1182\/blood.V89.3.1078","article-title":"Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter study of hydroxyurea","volume":"89","author":"Steinberg","year":"1997","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.bvth.2025.100114_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1182\/blood.2019003776","article-title":"Gene therapy for sickle cell disease: moving from the bench to the bedside","volume":"138","author":"Abraham","year":"2021","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bvth.2025.100114_bib22","first-page":"873","article-title":"Voxelotor: a hemoglobin S polymerization inhibitor for the treatment of sickle cell disease","volume":"11","author":"Yenamandra","year":"2020","journal-title":"J Adv Pract Oncol"},{"issue":"6","key":"10.1016\/j.bvth.2025.100114_bib23","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ajh.21699","article-title":"The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up","volume":"85","author":"Steinberg","year":"2010","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.bvth.2025.100114_bib24","first-page":"150","article-title":"Incidence of ocular abnormalities in patients with sickle hemoglobinopathies","volume":"18","author":"Friberg","year":"1986","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/j.bvth.2025.100114_bib25","article-title":"Epidemiology, pathogenesis, and clinical approach in group 5 pulmonary hypertension","volume":"7","author":"Al-Qadi","year":"2020","journal-title":"Front Med (Lausanne)"},{"issue":"7","key":"10.1016\/j.bvth.2025.100114_bib26","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood-2015-08-618561","article-title":"Pathophysiology and treatment of pulmonary hypertension in sickle cell disease","volume":"127","author":"Gordeuk","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.bvth.2025.100114_bib27","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017684","article-title":"Elevated pulmonary pressure noted on echocardiogram: a simplified approach to next steps","volume":"10","author":"Kanwar","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.bvth.2025.100114_bib28","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1182\/hematology.2019000038","article-title":"Osteonecrosis in sickle cell disease: an update on risk factors, diagnosis, and management","volume":"2019","author":"Adesina","year":"2019","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"5","key":"10.1016\/j.bvth.2025.100114_bib29","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.amjmed.2021.11.019","article-title":"Microalbuminuria constitutes a clinical action item for clinicians in 2021","volume":"135","author":"Rossing","year":"2022","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.bvth.2025.100114_bib30","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4103\/1319-2442.265459","article-title":"Prevalence and correlates of microalbuminuria in Yemeni children with sickle cell disease","volume":"30","author":"Al-Musawa","year":"2019","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"1","key":"10.1016\/j.bvth.2025.100114_bib31","first-page":"e6638","article-title":"Prevalence and risk factors for microalbuminuria in children with sickle cell disease at King Abdulaziz University Hospital: a retrospective cross-sectional study","volume":"12","author":"Alzahrani","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.bvth.2025.100114_bib32","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/5015764","article-title":"Prevalence of microalbuminuria in adult patients with sickle cell disease in Eastern Saudi Arabia","volume":"2018","author":"Alkhunaizi","year":"2018","journal-title":"Int J Nephrol"},{"issue":"10","key":"10.1016\/j.bvth.2025.100114_bib33","doi-asserted-by":"crossref","first-page":"E584","DOI":"10.1002\/ajh.24855","article-title":"Prospective evaluation of chronic organ damage in adult sickle cell patients: a seven-year follow-up study","volume":"92","author":"van Tuijn","year":"2017","journal-title":"Am J Hematol"},{"issue":"1","key":"10.1016\/j.bvth.2025.100114_bib34","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.26765","article-title":"Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease","volume":"98","author":"Kang","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.bvth.2025.100114_bib35","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8296139","article-title":"Association between participants' characteristics, patient-reported outcomes, and clinical outcomes in youth with sickle cell disease","volume":"2018","author":"Badawy","year":"2018","journal-title":"Biomed Res Int"},{"issue":"3","key":"10.1016\/j.bvth.2025.100114_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.4584","article-title":"Changes in hydroxyurea use among youths enrolled in Medicaid with sickle cell anemia after 2014 revision of clinical guidelines","volume":"6","author":"Reeves","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.bvth.2025.100114_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1056\/NEJMoa1813598","article-title":"Hydroxyurea for children with sickle cell anemia in sub-Saharan Africa","volume":"380","author":"Tshilolo","year":"2019","journal-title":"N Engl J Med"}],"container-title":["Blood Vessels, Thrombosis & Hemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327225000713?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950327225000713?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T15:11:00Z","timestamp":1772032260000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950327225000713"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2950327225000713"],"URL":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100114","relation":{},"ISSN":["2950-3272"],"issn-type":[{"value":"2950-3272","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of hemoglobin F in sickle cell disease complications: a descriptive secondary analysis","name":"articletitle","label":"Article Title"},{"value":"Blood Vessels, Thrombosis & Hemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bvth.2025.100114","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society of Hematology. Published by Elsevier Inc. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100114"}}